CAD and infection: Extending our investigation to determine the necessity of mTORC1-S6K1 activation for CAD phosphorylation at S1859, HFF cells were treated with the mTORC1 inhibitor rapamycin upon VACV-infection at a concentration that did not affect cell viability (53, 55).